1. Arbuthnott, G. W.: Studies on the interaction between the substantia nigra and the neostriatum. In: Adv. Biochem. Psychopharmacol., Vol. 19 (Roberts, P. J., Woodruff, G. N., Iversen, L. L., eds.). New York: Raven Press. 1978.
2. Ariens, E. J., Simonis, A. M., Van Rossum, J. M.: Drug-receptor interaction: Interaction of one or more drugs with one receptor system. In: Molecular Pharmacology (Ariens, E. J., ed.), pp. 119?286 (section IIA). London: Academic Press. 1964.
3. Arnt, J., Hyttel, J.: Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur. J. Pharmacol.102, 349?354 (1984 b).
4. Arnt, J., B�ges�, K. P., Hyttel, J., Larnen, J. -J., Svendsen, O.: Effects of S-(+)-3-phenethyl-PP, a putative dopamine autoreceptor agonist with greater autoreceptor selectivity than 3-PPP enantiomers. Eur. J. Pharmacol.102, 91?99 (1984).
5. Bannon, M. J., Bunney, E. B., Zigun, J. R., Skirboll, L. R., Roth, R. H.: Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol. Naunyn-Schmiedeberg's Arch. Pharmacol.312, 161?165 (1980).